In MM treatment, busulfan and Cy (BUCY) conditioning and ASCT followed by infusion of CD19 CAR T cells or their coupling with B cell maturation antigen (BCMA) CAR T cells is also a promising regimen (66, 71). Here, CD19 is linked to Miyoshi myopathy.